Anderson Hoagland & Co. increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 75.2% during the second quarter, Holdings Channel reports. The institutional investor owned 9,441 shares of the company’s stock after buying an additional 4,051 shares during the period. Anderson Hoagland & Co.’s holdings in Henry Schein were worth $1,728,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of HSIC. SpiderRock Advisors LLC bought a new stake in shares of Henry Schein during the first quarter worth approximately $102,000. Westside Investment Management Inc. acquired a new position in Henry Schein during the first quarter valued at about $168,000. JNBA Financial Advisors acquired a new position in Henry Schein during the first quarter valued at about $170,000. Peddock Capital Advisors LLC boosted its position in Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock valued at $186,000 after buying an additional 247 shares during the period. Finally, Van ECK Associates Corp boosted its position in Henry Schein by 5.7% in the first quarter. Van ECK Associates Corp now owns 1,138 shares of the company’s stock valued at $193,000 after buying an additional 61 shares during the period. 90.74% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Henry Schein, Inc. (NASDAQ:HSIC) traded down 0.73% during midday trading on Thursday, reaching $183.84. 193,439 shares of the company’s stock were exchanged. The firm has a market cap of $14.58 billion, a PE ratio of 27.94 and a beta of 1.09. Henry Schein, Inc. has a one year low of $146.23 and a one year high of $186.99. The stock’s 50-day moving average is $183.78 and its 200 day moving average is $172.72.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, May 9th. The company reported $1.76 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.65 by $0.11. Henry Schein had a net margin of 4.53% and a return on equity of 19.74%. The business had revenue of $2.92 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period in the previous year, the firm posted $1.41 earnings per share. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. Analysts anticipate that Henry Schein, Inc. will post $7.28 EPS for the current year.

WARNING: This story was originally published by Daily Political and is owned by of Daily Political. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at

HSIC has been the topic of several analyst reports. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating in a research report on Friday, June 23rd. Piper Jaffray Companies initiated coverage on Henry Schein in a research report on Monday, June 12th. They issued a “neutral” rating and a $200.00 price objective on the stock. Stifel Nicolaus reaffirmed a “hold” rating on shares of Henry Schein in a research report on Thursday, July 6th. Finally, Craig Hallum initiated coverage on Henry Schein in a research report on Tuesday, April 11th. They issued a “hold” rating on the stock. Eleven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $182.60.

In other news, EVP Gerald A. Benjamin sold 12,578 shares of Henry Schein stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $175.10, for a total transaction of $2,202,407.80. Following the completion of the sale, the executive vice president now directly owns 44,061 shares in the company, valued at $7,715,081.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.27% of the company’s stock.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with's FREE daily email newsletter.